机器人辅助的支气管镜技术的发展使得支气管镜医生能够更加自信、准确地进入肺部的外围区域。这主要归因于这些技术在机动性、延伸范围和稳定性方面的优势。尽管机器人辅助支气管镜有许多优势，但其使用也存在一些缺点，例如失去触觉反馈、需要解决计算机断层扫描（CT）与人体差异的问题以及可能对导航软件过度依赖的风险。目前在美国市场上有两种机器人辅助支气管镜平台，分别为Auris Health©公司的MonarchTM平台（位于加利福尼亚州雷德伍德市）和Intuitive Surgical©公司的IonTM内腔机器人支气管镜平台（位于加利福尼亚州桑尼维尔市）。在本临床案例回顾中，我们重点介绍了使用这两种机器人辅助支气管镜平台进行肺部病灶取样的证据和策略。具体而言，我们将回顾术前考虑因素，如程序映射、手术室布置和麻醉注意事项。我们还将回顾使用机器人辅助支气管镜平台的技术方面，例如如何补偿失去的触觉反馈，优化可视化，使用辅助技术以解决计算机断层扫描与人体差异的问题，使用最佳取样技术，并利用现场快速评估（ROSE）的信息来提高诊断结果。2023 Annals of Translational Medicine. 版权所有。

The development of robotic-assisted bronchoscopy has empowered bronchoscopists to access the periphery of the lung with more confidence and promising accuracy. This is due in large to the superior maneuverability, further reach, and stability of these technologies. Despite the advantages of robotic bronchoscopy, there are some drawbacks to using these technologies, such as the loss of tactile feedback, the need to overcome computed tomography (CT)-to-body divergence, and the potential for overreliance on the navigation software. There are currently two robotic bronchoscopy platforms on the US market, the MonarchTM Platform by Auris Health© (Redwood City, CA, USA) and the IonTM endoluminal robotic bronchoscopy platform by Intuitive Surgical© (Sunnyvale, CA, USA). In this clinical practice review, we highlight the evidence and strategies for successful clinical use of both robotic bronchoscopy platforms for pulmonary lesion sampling. Specifically, we will review pre-procedural considerations, such as procedural mapping, room set-up and anesthesia considerations. We will also review the technical aspects of using the robotic bronchoscopy platforms, such as how to compensate for the loss of tactile feedback, optimize visualization, use of ancillary technology to accommodate for CT-to-body divergence, employ best practices for sampling techniques, and utilize information from rapid on-site evaluation (ROSE) to aid in improving diagnostic yield.2023 Annals of Translational Medicine. All rights reserved.